Diallyl trisulfide alleviates chemotherapy sensitivity of ovarian cancer via the AMPK/SIRT1/PGC1α pathway

Platinum‐based chemotherapy promotes drug resistance in ovarian cancer. We investigated the antichemoresistance characteristics of diallyl trisulfide (DATS) in cisplatin‐resistant ovarian cancer cells, in vitro and in vivo. Previous preclinical studies have revealed that DATS regulates distinct hall...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhaojun, Yan, Yi, Lou, Yijie, Huang, Xiaoyan, Liu, Lijian, Weng, Zhuofan, Cui, Yusheng, Wu, Xinyue, Cai, Huijun, Chen, Xiaohui, Ji, Yunxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899624/
https://www.ncbi.nlm.nih.gov/pubmed/36309839
http://dx.doi.org/10.1111/cas.15627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899624/
https://www.ncbi.nlm.nih.gov/pubmed/36309839
http://dx.doi.org/10.1111/cas.15627

Ejemplares similares